CIK 0000882095
- Large accelerated filer
GILEAD SCIENCES, INC.
Sign in to watch- Ticker
- GILD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943047598
- Phone
- +1 650-574-3000
- Business address
- 333 LAKESIDE DR, FOSTER CITY, CA, 94404
- Former names
- GILEAD SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $36,996,096
- in 12 filings, $37.0M under 10b5-1 plans
Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-10 | O'Day Daniel Patrick Chairman & CEO | Option exercise · Restricted Stock Unit | −10,427 | 98,496 | ||
| 2025-09-10 | Wilfong Diane E. Interim Corp Controller & CAO | Option exercise | +921 | 46,597 | ||
| 2025-09-10 | Wilfong Diane E. Interim Corp Controller & CAO | Shares withheld for taxes | −338 | $115.25 | $39K | 46,259 |
| 2025-09-10 | Wilfong Diane E. Interim Corp Controller & CAO | Option exercise · Restricted Stock Unit | −921 | 7,864 | ||
| 2025-09-10 | Dickinson Andrew D Chief Financial Officer | Option exercise | +3,696 | 163,806 | ||
| 2025-09-10 | Dickinson Andrew D Chief Financial Officer | Shares withheld for taxes | −1,751 | $115.25 | $202K | 162,055 |
| 2025-09-10 | Dickinson Andrew D Chief Financial Officer | Option exercise · Restricted Stock Unit | −3,696 | 31,219 | ||
| 2025-08-28 | O'Day Daniel Patrick Chairman & CEO | Sale 10b5-1 | −10,000 | $113.63 | $1.1M | 595,725 |
| 2025-08-15 | Dickinson Andrew D Chief Financial Officer | Sale 10b5-1 | −2,500 | $118.53 | $296K | 160,110 |
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Option exercise 10b5-1 | +11,800 | $66.64 | $786K | 128,968 |
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −11,800 | $118.50 | $1.4M | 117,168 |
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Option exercise 10b5-1 | +700 | $66.64 | $47K | 117,868 |
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −700 | $118.97 | $83K | 117,168 |
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Option exercise 10b5-1 | +11,800 | $66.64 | $786K | 128,968 |
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −11,800 | $118.51 | $1.4M | 117,168 |
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Option exercise 10b5-1 | +700 | $66.64 | $47K | 117,868 |
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −700 | $118.97 | $83K | 117,168 |
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −2,800 | $118.51 | $332K | 114,368 |
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Sale 10b5-1 | −200 | $118.97 | $24K | 114,168 |
| 2025-08-15 | Mercier Johanna Chief Commercial Officer | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −11,800 | 111,310 |
Page 14 of 30 · 599 trades